| Literature DB >> 34009516 |
Miao Wang1,2,3, Liying Wang1,2,3, Haizhou Liu1,2, Jianjun Chen1,2, Di Liu4,5,6,7.
Abstract
Human endogenous retroviruses (HERVs) are the remains of ancient retroviruses that invaded our ancestors' germline cell and were integrated into the genome. The expression of HERVs has always been a cause for concern because of its association with various cancers and diseases. However, few previous studies have focused on specific activation of HERVs by viral infections. Our previous study has shown that dengue virus type 2 (DENV-2) infection induces the transcription of a large number of abnormal HERVs loci; therefore, the purpose of this study was to explore the relationship between exogenous viral infection and HERV activation further. In this study, we retrieved and reanalyzed published data on 21 transcriptomes of human cells infected with various viruses. We found that infection with different viruses could induce transcriptional activation of HERV loci. Through the comparative analysis of all viral datasets, we identified 43 key HERV loci that were up-regulated by DENV-2, influenza A virus, influenza B virus, Zika virus, measles virus, and West Nile virus infections. Furthermore, the neighboring genes of these HERVs were simultaneously up-regulated, and almost all such neighboring genes were interferon-stimulated genes (ISGs), which are enriched in the host's antiviral immune response pathways. Our data supported the hypothesis that activation of HERVs, probably via an interferon-mediated mechanism, plays an important role in innate immunity against viral infections.Entities:
Keywords: Human endogenous retrovirus (HERV); Interferon-stimulated genes (ISGs); RNA-seq; Virus infection
Mesh:
Substances:
Year: 2021 PMID: 34009516 PMCID: PMC8131884 DOI: 10.1007/s12250-021-00370-2
Source DB: PubMed Journal: Virol Sin ISSN: 1995-820X Impact factor: 4.327
Summary of samples used in this study.
| Virus | Hours post-infection | Virus strain | Cell | Accession number |
|---|---|---|---|---|
| DENV-2 | 72 | TSV01 | A549 | PRJNA552644 |
| Flu-A | – | PR8 | A549 | PRJNA495858 |
| Flu-B | – | B/Yamagata | A549 | PRJNA605905 |
| ZIKV | 48 | FSS13025 | hiNPCs | PRJNA551246 |
| 48 | PE243V | hiNPCs | ||
| HCV | 12 | – | Huh7 | PRJNA559203 |
| 36 | – | Huh7 | ||
| 60 | – | Huh7 | ||
| WNV | – | – | A549 | PRJNA577579 |
| CCHFV | 24 | – | Huh7 | PRJNA549926 |
| 72 | – | Huh7 | ||
| 24 | – | HepG2 | ||
| 72 | – | HepG2 | ||
| EBV | – | Akata | differentiated NOKs | PRJNA555053 |
| – | Akata | undifferentiated NOKs | ||
| MV | – | – | MSC (5H) | PRJNA545099 |
| – | – | MSC (hTERT) | ||
| RSV | 24 | A2 | A549 | PRJNA615032 |
| SARS-CoV-2 | 24 | USA-WA1/2020 | A549 | PRJNA615032 |
| 24 | USA-WA1/2020 | NHBE | ||
| RHV | 6 | – | Calu3 | PRJNA609228 |
| 24 | – | Calu3 |
Fig. 1PCA analysis of the transformed expression values of human genes (A) and HERV loci (B).
Summary of differentially expressed human genes and HERVs in each dataset.
| Dataset | Number of DEGa | Number of DEHERVb | ||||
|---|---|---|---|---|---|---|
| Up-regulated | Down-regulated | Total | Up-regulated | Down-regulated | Total | |
| DENV-2 | 2942 | 1759 | 4701 | 2352 | 681 | 3033 |
| Flu-A | 5341 | 3789 | 9130 | 4810 | 1989 | 6799 |
| Flu-B | 3667 | 1877 | 5544 | 1408 | 1078 | 2486 |
| ZIKV_F | 1072 | 274 | 1346 | 536 | 68 | 604 |
| ZIKV_P | 408 | 49 | 457 | 270 | 12 | 282 |
| HCV_12h | 4 | 4 | 8 | 0 | 0 | 0 |
| HCV_36h | 354 | 49 | 403 | 152 | 2 | 154 |
| HCV_60h | 1118 | 345 | 1463 | 208 | 33 | 241 |
| WNV | 825 | 52 | 877 | 349 | 6 | 355 |
| CCHFV_Huh7_24h | 12 | 0 | 12 | 6 | 0 | 6 |
| CCHFV_Huh7_72h | 559 | 348 | 907 | 147 | 61 | 208 |
| CCHFV_HepG2_24h | 44 | 1 | 45 | 20 | 0 | 20 |
| CCHFV_HepG2_72h | 121 | 77 | 198 | 45 | 8 | 53 |
| EBV_differented-NOKs | 237 | 772 | 1009 | 245 | 146 | 391 |
| EBV_undifferented-NOKs | 90 | 173 | 263 | 70 | 36 | 106 |
| MV_MSC(5H) | 1383 | 115 | 1498 | 1128 | 85 | 1213 |
| MV_MSC(hTERT) | 733 | 191 | 924 | 319 | 64 | 383 |
| RSV | 430 | 229 | 659 | 69 | 6 | 75 |
| SARS-CoV-2_A549 | 32 | 1 | 33 | 6 | 0 | 6 |
| SARS-CoV-2_NHBE | 104 | 23 | 127 | 14 | 3 | 17 |
| RHV_6h | 1 | 0 | 1 | 2 | 1 | 3 |
aDifferentially expressed human gene; bdifferentially expressed HERV.
Fig. 2Identification of DEHERV-G pairs in each dataset. A Number of DEHERV-G pair. B Proportion of DEHERV-G pairs in four expression patterns. Only datasets with more than 10 DEHERV-G pairs are shown.
Fig. 3Screening for key DEHERV-G pairs associated with viral infection. A Veen diagram of key DEHERV-G pair enriched in six datasets. The pairs constituting the intersection of all datasets are considered to be the key DEHERV-G pairs. B Distribution of the components of the 43 key DEHERV-G pairs on chromosomes. The red letter represents human gene, and the blue letter represents HERV site. C Location of DEHERV loci relative to human genes. UTR: untranslated region; TSS: transcription start site; TES: transcription end site.
Fig. 4Characteristics of the components of 43 key DEHERV-G pairs. A Count of HERVs in different categories. The height of the columns represents the number of HERVs. B PPI network of human genes. The circle represents protein-coding gene, in which the red filled represents interferon induced genes, and the triangle represents lncRNA. C GO enrichment analysis of human genes. D KEGG enrichment analysis of human genes. E Distribution of the key DEHERV-G pairs in interform-beta or ploy(I:C)-stimulated cells.